levosulpiride

This page covers all levosulpiride drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(4) dopamine receptor, Myeloperoxidase, D(2) dopamine receptor.

Targets

D(4) dopamine receptor, Myeloperoxidase, D(2) dopamine receptor

Phase 2 pipeline (1)

• Lesuride · Gastroenterology
  Lesuride works by binding to dopamine D(2) receptors in the brain, which helps to regulate gut motility and secretion.

Patent intelligence

• levosulpiride patent landscape — aggregated cliff calendar, attackable patents, originator estates